questran การใช้

• Questran is not absorbed by the body.
• The panel unanimously recommended against allowing the over-the-counter sale of Questran.
• Prospects for increased sales were clouded by the fact that Questran is a difficult medication to take.
• Patients with phenylketonuria should consult with a physician before taking Questran Light because that product contains phenylalanine.
• While a variety of medications are prescribed by cardiologists and family physicians, Questran is most recommended to fight high cholesterol.
• Questran has been taken by Americans for over 20 years, with minimal side effects such as constipation, gas and bloating.
• The panel today heard results from the company's new study of 2, 000 consumers who took Questran over three months.
• Bristol-Myers clearly cautions against taking Questran unless a doctor has first diagnosed high cholesterol and recommended it along with a low-fat diet.
• But only 6 million Americans are on diet therapy for high cholesterol and about 4 million on medication, including 500, 000 who take Questran.
• Questran and a low-fat diet have been shown to lower patients'levels of the " bad " cholesterol by 25 percent.
• According to analysts, OTC classification would likely have a slim impact on the market share for Questran, which currently has annual sales of around $ 100 million.
• Patients also would have to understand the importance of not taking Questran at the same time of day as certain other drugs because of the potential for harmful interactions.
• An unpleasant tasting powder which is stirred into juice, water or yogurt, Questran causes bloating, indigestion, and constipation in some 20 percent of those who take the drug.
• Bristol-Myers Squibb Co . today failed to win the backing of a U . S . Food and Drug Administration expert panel to market its anti-cholesterol medication Questran over the counter.
• Questran is marketed by the New York-based pharmaceutical company on a prescription basis, and would be the lone non-prescription medication for treating high blood lipid levels-a main risk factor for heart disease.
• At meetings this month, Food and Drug Administration advisory panels will consider applications for nonprescription versions of Questran, a cholesterol-lowering drug made by Bristol-Myers Squibb, and Nicorette chewing gum, from Marion Merrell Dow, a unit of Hoechst AG, aimed at smokers trying to quit.